Clinical Trials

Intellia Backs Lonvo-z as One-Time CRISPR Therapy for HAE in Phase 3 HAELO

Intellia Backs Lonvo-z as One-Time CRISPR Therapy for HAE in Phase 3 HAELO Read Post »